Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a new page build. It does not modify the study details themselves.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedClinicalTrials.gov page footer revision updated from v3.5.2 to v3.5.3, indicating a platform/build version change rather than substantive study information.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check67 days agoChange DetectedThe revision tag on the page has been updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check81 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check103 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.